- J Sykes,
- R Johnson,
- G W Hanks
Introduction
Roughly 80-90% of pain due to cancer can be relieved relatively simply with oral analgesics and adjuvant drugs in accordance with the World Health Organisation's guidelines. The remaining 10-20% can be difficult to treat.
Useful adjuvant analgesics for neuropathic pain
Our practice is to start with amitriptyline and add an anticonvulsant if the symptoms are not relieved or to substitute an anticonvulsant if the tricyclic is poorly tolerated. If pain is still uncontrolled at this stage, referral for a specialist palliative care opinion or to a pain clinic is advisable
Corticosteroids (for example, dexamethasone 8 mg daily) may be used to reduce inflammation and oedema around a tumour if these are causing nerve compression
Tricyclic antidepressants—The analgesic effect of tricyclics is independent of any antidepressant effect. Mixed reuptake inhibitors such as amitriptyline seem to be more effective analgesics than the selective serotonin reuptake inhibitors. The starting dose should be low (such as amitriptyline 10–25 mg at night) and then titrated upwards on a weekly basis until pain control improves or side effects become intolerable. An analgesic response has been found with amitriptyline within the range 25–75 mg, but, as the dose increases, so does the frequency of unwanted effects (the evidence of analgesic activity is much less strong for drugs other than amitriptyline)
Anticonvulsants—Doses should start low and be titrated upwards. Sodium valproate (200 mg twice daily up to 1600 mg a day) is often better tolerated than carbamazepine (200 mg at night up to 400 mg twice daily)
Antiarrhythmic drugs—These are reserved as second or third line drugs, when treatment with antidepressant or anticonvulsant, or both, has failed. Mexiletine (50-200 mg thrice daily) is usually the first choice in this class
Corticosteroids (for example, dexamethasone 8 mg daily) may be used to reduce inflammation and oedema around a tumour if these are …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012